Tumor-selective killing by selenite in patient-matched pairs of normal and malignant prostate cells
- 1 February 2006
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 66 (2), 218-225
- https://doi.org/10.1002/pros.20337
Abstract
Selenium compounds have been shown to induce apoptosis in a variety of human prostate cancer cell lines. However, the effects of selenium have yet to be examined in normal and malignant cells derived from the same individual. Selenite metabolism consumes glutathione (GSH) and produces superoxide. The generation of reactive oxygen species is an important mechanism in selenite-induced apoptosis. Three patient-matched pairs of primary prostatic epithelial cell cultures from normal and cancer were evaluated for their response to selenite. Apoptosis was measured and the differential response of normal and cancer cells was correlated with the expression of bcl-2, bax, GSH, and manganese superoxide dismutase (MnSOD). The cancer-derived cells were significantly more sensitive to selenite-induced apoptosis than the corresponding normal cells. Tumor-selective killing was not observed in cells treated with selenomethionine. The ratio of bcl-2:bax was decreased in the cancer-derived cells treated with selenite. Total GSH concentrations were similar in paired normal and cancer cells. Therefore, differences in GSH content do not appear to play a role in tumor-selective killing by selenite. Superoxide is a by-product of selenite metabolism and normal cells showed increased MnSOD expression and SOD activity compared to the cancer-derived cells. Prostate cancer cells treated with the MnSOD mimetic, MnTMPyP, were protected against the cytotoxic effects of selenite. Higher MnSOD expression in normal cells may play an important role in eliminating superoxide radicals produced as a result of selenite metabolism and contribute to the tumor-selective killing by selenite in prostate cancer.Keywords
This publication has 23 references indexed in Scilit:
- Redox modulation of human prostate carcinoma cells by selenite increases radiation-induced cell killingFree Radical Biology & Medicine, 2005
- Alteration of Cellular Phenotype and Responses to Oxidative Stress by Manganese Superoxide Dismutase and a Superoxide Dismutase Mimic in RWPE-2 Human Prostate Adenocarcinoma CellsAntioxidants and Redox Signaling, 2004
- Rapid induction of apoptosis in prostate cancer cells by selenium: reversal by metabolites of arachidonate 5-lipoxygenaseBiochemical and Biophysical Research Communications, 2004
- Superoxide radical–initiated apoptotic signalling pathway in selenite-treated HepG2 cells: mitochondria serve as the main targetFree Radical Biology & Medicine, 2000
- Chemopreventive AgentsPharmacology & Therapeutics, 1998
- Expression of antioxidant enzymes in human prostatic adenocarcinomaThe Prostate, 1997
- Effects of Selenium Supplementation for Cancer Prevention in Patients With Carcinoma of the SkinJAMA, 1996
- On the nature of selenium toxicity and carcinostatic activityFree Radical Biology & Medicine, 1994
- Active Oxygen Generation by the Reaction of Selenite with Reduced Glutathione in VitroPublished by Springer Science and Business Media LLC ,1989
- Selenium Distribution and Human Cancer MortalityCRC Critical Reviews in Clinical Laboratory Sciences, 1971